Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cobalt Speech and Language is a commercial speech AI company that develops automatic speech recognition, natural language understanding, voice biometrics, text-to-speech, and conversational voice interface technologies. The company is best known for privacy-conscious, customizable deployments that can run on premises, in private cloud environments, or on embedded devices for enterprise and mission-critical use cases. Although it is not a biotech or pharma drug developer, it has healthcare relevance through speech-analysis products such as SPICE, which supports speech-language pathologists and educators with AI-assisted pronunciation and articulation assessment. Cobalt serves industries including healthcare, contact centers, government, and industrial applications. In 2025, the company was acquired by Quansight and continues to operate as a distinct team within Quansight.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cobalt Speech and Language.